New drug indication approval - November 2023

Product Name

ELIDEL CREAM 1% W/W

Active Ingredient (Strength)

Pimecrolimus(10 mg/g)

Product Registrant

PHARMLINE MARKETING PTE. LTD.

Date of Approval

20/11/2023

Indications:

Elidel 1% cream is indicated for the short-term and intermittent long-term therapy in the treatment of mild to moderate atopic dermatitis in nonimmunocompromised patients 3 months of age and older, in whom the use of alternate, conventional therapies is deemed inadvisable because of the
potential risks, or in the treatment of patients who are not adequately responsive to or intolerant of alternative, conventional therapies.

 

Healthcare professional, Industry member, Therapeutic Products
Published:

New Drug Indication Approvals